The Chief Executive Officer and President of Artiva Biotherapeutics is Dr. Fred Aslan, M.D. He has led the clinical-stage biotechnology enterprise since January 2021, guiding its strategic transition into allogeneic natural killer cell therapeutics, regulatory milestones, and public market capital raises. He brings extensive life sciences executive and investment experience to the role.